Technology News and Research

RSS

Neuronetics raises funds to expand sales team for NeuroStar TMS Therapy

New Leaf Venture Partners (NLV Partners) announced today it has led a $30 million Series D financing round in Neuronetics, Inc., maker of NeuroStar TMS (Transcranial Magnetic Stimulation) Therapy® for the treatment of depression.

3 Sep 2009

Reproductive Partners Medical Group receives Mayor's Commendation

Reproductive Partners Medical Group was awarded a Mayor's Commendation at its September 1st City Council Meeting. The commendation, presented to Drs. David Meldrum, Arthur Wisot and Bill Yee by Mayor Michael Gin and City Councilman Steven Diels cited recognition of the practice "giving hope to many couples in our South Bay Community."

3 Sep 2009

Clinical research paper on 2D gel electrophoresis for identifying protein biomarkers

Transgenomic, Inc. and Power3 Medical Products, Inc. (OTC Bulletin Board: PWRM) today announced the advance on-line publication of a clinical research paper entitled "Abnormal Serum Concentrations of Proteins in Parkinson's Disease" in the scientific journal Biochemical and Biophysical Research Communications.

3 Sep 2009

eCardio is #117 on the 2009 Inc. 500 list

eCardio announced today their inclusion on the Inc. magazine's annual list of America's fastest-growing private companies - the Inc. 500. Inc. magazine released the list on Wednesday, August 12. eCardio was included in the top quarter as #117 with a three-year sales growth of 1,424%.

3 Sep 2009

Implanet to use IBM's sensor technology for its new implant device tracking service

Implanet, a manufacturer of implantable medical devices, has selected IBM (NYSE: IBM) sensor technology as the foundation for BeepN'Track, a new service that traces the movement of Implanet's products - including knee and hip implants - across its supply chain to hospitals.

3 Sep 2009

Tucson Orthopaedic Institute chooses CoreTrace's BOUNCER endpoint system protection solution

CoreTrace, the pioneer of client-based application whitelisting technology, today announced that Tucson Orthopaedic Institute, one of the largest orthopaedic groups in the United States, has selected CoreTrace's award-winning BOUNCER solution for endpoint protection of its systems located throughout the Institute's eight centers.

3 Sep 2009

Clinical trial results of sumatriptan published in a journal

NovaDel Pharma Inc. announced that an article titled “Rapid Oral Transmucosal Absorption of Sumatriptan, and Pharmacodynamics in Acute Migraine” was published online on June 22, 2009 in the peer-reviewed journal Headache: The Journal of Head and Face Pain.

3 Sep 2009

National Cancer Institute awards grant to Receptor Logic for breast cancer research

Receptor Logic, Inc. announced today receipt of a Phase I Small Business Technology Transfer (STTR) Grant from the National Cancer Institute. The grant, entitled “Therapeutic Effectiveness of T-Cell Receptor mimic (TCRm™) Antibodies in Breast Cancer Treatment” will accelerate Investigational New Drug Application enabling studies surrounding lead candidate TCRm antibodies.

3 Sep 2009

IPC The Hospitalist Company acquires Hospital Medicine Associates

IPC The Hospitalist Company, Inc., a leading national hospitalist physician group practice company, announced today that it has acquired Hospital Medicine Associates, P.C. (HMA).

3 Sep 2009

NetBase Solutions launches healthBase Content Intelligence platform

NetBase Solutions, Inc. today launched healthBase (healthbase.netbase.com), a public showcase of NetBase's Content Intelligence platform, which is able to read sentences inside documents, linguistically understand the meaning and power breakthrough search and discovery solutions.

3 Sep 2009

Accuracy of the LENA Autism Screen increased

LENA Foundation has increased the accuracy of the LENA Autism Screen (LAS) to 91 percent for children 24 to 48 months. LAS - the first automatic and totally objective autism screen - is now as accurate or more accurate than other autism screens currently available to parents and clinicians.

3 Sep 2009

Aerocrine’s NIOX MINO technology approved in Canada for treating asthma

Aerocrine AB (STO:AEROB) today announced that Health Canada’s Therapeutic Products Directorate has approved Aerocrine’s NIOX MINO® technology for use in treating asthma. Canada’s National Health Service may now begin using the NIOX MINO, a medical device that provides a measure of the degree of inflammation in the airways in a single breath.

3 Sep 2009

Strelitz Diabetes Center awarded a two-year grant for 12-LO research

Scientists at Eastern Virginia Medical School's Strelitz Diabetes Center have been awarded a two-year grant totaling $472,683 by the Juvenile Diabetes Research Foundation (JDRF).

3 Sep 2009

New device for treating hypoglycemia launched globally

At this year’s annual meeting of the International Society for Pediatric and Adolescent Diabetes (ISPAD) in Ljubljana, Slovenia, Medtronic, Inc. announced the global launch of a novel technology designed to provide additional protection against the risks associated with hypoglycemia.

3 Sep 2009

m.pulse system for MCP therapy installed in ten hospitals

Cardiola AG announced today that it has placed its patented m.pulse system in 10 hospitals located in Germany and Switzerland, on the heels of the system’s CE-Mark approval. MCP was previously only available in a clinical setting. Now, m.pulse is the world’s first and only device enabling CAD patients to receive MCP therapy at home.

3 Sep 2009

Healthcare-acquired infection costs $1 billion per annum

Infections caught in hospital are costing the Australian healthcare system more than 850,000 lost bed days, according to a new study by Queensland University of Technology.

3 Sep 2009

Molecular pathology laboratories gear up for swift swine flu detection

Dr. Jan Nowak, President of the Association for Molecular Pathology presented public comments today at the Clinical Laboratory Improvement Advisory Committee meeting.

3 Sep 2009

Abbott to acquire Visiogen for $400 million in cash

Abbott (NYSE: ABT) announced today a definitive agreement to acquire Visiogen, Inc. for $400 million in cash, providing the company with a next-generation accommodating intraocular lens (IOL) technology to address presbyopia for cataract patients.

3 Sep 2009

MRG's new report on neurovascular embolectomy device market

According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the emerging market for neurovascular embolectomy devices for the treatment of acute ischemic stroke is poised for healthy yet conservative growth of close to 15% annually in Europe over the next 5 years.

3 Sep 2009

Colorado braces for mental health cuts, Florida nursing homes brace for Medicare cuts, and other developments

Kaiser Health News: "Three years after Massachusetts implemented a state program to provide near universal health care, officials said that a key to their success was that stakeholders from the state's health care sector and the business community had a commitment to implementing the program." Despite successes, one state official said cost containment remains a challenge (Marcy, 9/1).

3 Sep 2009